Does Strattera (atomoxetine) need to be tapered when discontinuing a 40 mg dose?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 8, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Strattera Does Not Need to Be Tapered When Discontinuing at 40mg

Strattera (atomoxetine) can be discontinued abruptly at 40mg without tapering, as explicitly stated in the FDA prescribing information. 1

Direct FDA Guidance

The FDA-approved prescribing information clearly states: "STRATTERA can be discontinued without being tapered." 1 This applies to all doses, including 40mg, and represents the highest-quality evidence available for this specific medication.

Supporting Clinical Evidence

Multiple prospective studies confirm this guidance:

  • A large prospective, placebo-controlled study specifically assessed discontinuation effects after 9-10 weeks of continuous atomoxetine therapy in both children and adults with ADHD. The study found no statistically significant differences in discontinuation-emergent adverse events between patients who abruptly stopped atomoxetine versus those continuing on placebo. The authors concluded: "Tapering of doses is not necessary when atomoxetine is discontinued." 2

  • Additional research confirms that atomoxetine discontinuation is well tolerated with a low incidence of discontinuation-emergent adverse events, and patients may miss occasional doses without rebound effects or discontinuation syndrome 3, 4, 5

Clinical Context: Why Atomoxetine Is Different

Unlike medications that commonly require tapering (SSRIs, benzodiazepines, antipsychotics for tics, or lithium for mania), atomoxetine does not produce:

  • Withdrawal symptoms requiring gradual dose reduction
  • Symptom rebound to levels worse than baseline
  • Discontinuation syndrome

While general pediatric psychopharmacology guidelines recommend tapering medications slowly to avoid withdrawal or rebound symptoms 6, these recommendations specifically cite examples like benzodiazepines, SSRIs, antipsychotics, and lithium—not atomoxetine.

Important Monitoring Considerations

Although tapering is not required, you should still:

  • Monitor for return of ADHD symptoms over the following weeks, as symptoms may gradually worsen (though not rebound below baseline levels) 2
  • Recognize that hyperactivity symptoms may return within hours to days, while inattentive symptoms may take longer to re-emerge 6
  • Develop a monitoring plan before discontinuation to assess whether continued treatment is needed

Common Pitfall to Avoid

Do not confuse the gradual return of ADHD symptoms with a discontinuation syndrome. The prospective studies showed that while ADHD symptoms worsened after stopping atomoxetine, they did not return to pretreatment levels and this represents the natural course of untreated ADHD, not a withdrawal effect 2.

Related Questions

For Strattera (atomoxetine) taken at 50 mg daily by mouth, is a taper required when discontinuing?
Can I start atomoxetine (Strattera) on a patient who has been off medication for a long period and was previously treated with stimulant medications for ADHD?
A patient on Strattera (atomoxetine) 60 mg reports persistent difficulty concentrating and focusing; what advice should be given?
A 6-year-old child taking atomoxetine (Strattera) 50 mg daily is not showing improvement; what is the next step in management?
In an 11-year-old child taking atomoxetine 40 mg who presents with chest pain, should the medication be discontinued and what evaluation is recommended?
Can hyperthyroidism cause an elevated serum human chorionic gonadotropin (hCG) level?
What is the significance of sharp waves on an electroencephalogram (EEG) in a person who has never experienced seizures?
What is the recommended antibiotic prophylaxis for orthopedic surgery, including the preferred first‑generation cephalosporin dose and timing, repeat dosing for prolonged cases, alternatives for severe penicillin allergy, and maximum duration of postoperative prophylaxis?
What antibiotic regimen is appropriate for a dog bite in a patient allergic to amoxicillin and cephalexin (Keflex)?
What are the key antibiotic interactions with vitamin K antagonists (e.g., warfarin) and direct oral anticoagulants (e.g., apixaban, rivaroxaban, edoxaban, dabigatran), and how should dosing and INR monitoring be managed?
What platelet count target should be maintained for a patient with myelodysplastic syndrome and pancytopenia?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.